What's new

PSUSA/00000210/202408

PSUSA/00000210/202408

May 28, 2025 - 14:55
 0
PSUSA/00000210/202408
PSUSA/00000210/202408
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about a biotech IPO slump, FDA oversight of p...

Next Article

PSUSA/00001603/202408

Related Posts

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

May 26, 2025  0

Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0